Vanberra Signal

OphtAI

Curated by Signal

Provider of AI-based solution for screening and diagnosis for eye pathologist

Overview

OpthAI provides an AI-based solution for screening and diagnosis for eye pathologists. It offers an analysis of the surface of the eye with the cornea, all the way to the retina. The use of AI and deep learning in image processing and analysis paves the way for massive screening of retinal diseases, in real-time.

Key facts

Founded
2019

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Online platform for personalized nutrition and healthy food recommendations

    Health TechnologyFrancheville, France
  • Provider of ovulation tests and diagnostic tools for reproduction management in cattle

    Health TechnologyNouzilly, France
  • Provider of a self-refraction solution for optometrists

    Health TechnologyAjaccio, France

About OphtAI

What does OphtAI do?

OpthAI provides an AI-based solution for screening and diagnosis for eye pathologists.

Where is OphtAI headquartered?

OphtAI is headquartered in Villers Bretonneux, France.

When was OphtAI founded?

OphtAI was founded in 2019.

Which sector is OphtAI in?

OphtAI operates in Health Technology.

Who are OphtAI's competitors?

Companies similar to OphtAI include Nutrisens, ReproPharm Vet, and Glasspop.